founderscorner

Jian Zuo, CEO and Co-founder of Ting Therapeutics, discusses how his company is developing a better solution for hearing loss.

Third Element Bio Founder, Carter Palmer, discusses with FCVC mentors how their company is utilizing big data analytics to mine human sequencing datasets as part of a discovery pipeline for novel therapeutics.

President and CEO Dominic King-Smith discusses the innovative therapies for diseases of epithelial barrier impairment that Enzen Therapeutics is developing.

We recently hosted a spooktacular Halloween Bash at Founders Corner, bringing together the vibrant community of FC mentors and former presenters. It was an afternoon filled with laughter, reminiscing, and sharing stories from the past year. We were thrilled to see old connections rekindled and new friendships formed, proving once again that Founders Corner is

Last month at Founders Corner, we had the privilege of hosting a panel discussion featuring Dr. Angie You and Dr. Laura Shawver, moderated by Dr. Carol Gallagher. The event was a celebration of women’s achievements in the industry, uniting early-stage founders and seasoned industry leaders. We learned about the challenges and insecurities that take place when running

We really enjoyed the lightning talk ⚡️ with Personal.ai Co-Founder & CTO Sharon Zhang recently where she took a deep dive into the evolution of their AI’s capabilities. Fascinating stuff, extremely helpful for entrepreneurs looking to become efficient and for those looking to memorialize and access important data in a meaningful way. Thanks to the hosts Neal Bloom, Arjun Bansal, Nick Edwards,

A great gathering of AI x Bio x SD experts! Lightening talks on AI agents and AI/proteomics for better drug discovery by Log10.io & Yatiri Bio Inc.

Great turnout at the Founders Corner and excellent presentation from the Orphagen Pharmaceuticals team – Scott Thacher, Haiyan Tao, Paul Crowe. Thank you to the mentors who carved out time this afternoon to provide insightful feedback on strategy and positioning. Orphagen is a pioneer in the screening, discovery and development of ligands that modulate orphan or unexplored members of the nuclear

Thank you to Andrew Rudd of Palm Therapeutics for his presentation to FCVC and a special thanks to our FC mentors for carving out time to provide valuable feedback around strategy and positioning. Palm Therapeutics is a San Diego-based biotech startup (JLABS Resident) developing first-in-class palmitoylation inhibitors in the oncology space. Currently raising a seed

Great turnout for f5 Therapeutics FCVC talk this month! Thanks to Gary Choy for an excellent presentation and to all the mentors for dedicating time and energy toward giving good feedback to our entrepreneur. And of course thanks to John Hood for kicking off the FCVC session 💪🏽